North America’s medical devices industry saw a rise of 42.86% in cross border deal activity during December 2020, when compared with the last 12-month average, led by Koninklijke Philips‘ $2.8bn acquisition of BioTelemetry, according to GlobalData’s deals database.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 20 medical devices industry cross border deals worth $4.79bn were announced for the region in December 2020, against the 12-month average of 14 deals.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Of all the deal types, venture financing saw most activity in December 2020 with ten transactions, representing a 50% share for the region.

In second place was M&A with eight deals, followed by private equity deals with two transactions, respectively capturing a 40% and 10% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, M&A was the leading category in North America’s medical devices industry with $3.52bn, while private equity and venture financing deals totalled $772.47m and $500.19m, respectively.

North America medical devices industry cross border deals in December 2020: Top deals

The top five medical devices cross border deals accounted for 88% of the overall value during December 2020.

The combined value of the top five medical devices cross border deals stood at $4.21bn, against the overall value of $4.79bn recorded for the month.

The top five medical devices industry cross border deals of December 2020 tracked by GlobalData were:

1) Koninklijke Philips’ $2.8bn acquisition of BioTelemetry

2) The $700m private equity deal with Verily Life Sciences by Alphabet, Ontario Teachers’ Pension Plan, Silver Lake Partners and Temasek Holdings (Private)

3) Richter Gedeon Nyrt’s $263.5m asset transaction with Janssen Pharmaceutica

4) The $250m acquisition of EmendoBio by AnGes

5) Baillie Gifford, Franklin Templeton Investments, Google, Novo Holdings and T Rowe Price Associates’ venture financing of Tempus Labs for $200m.